Interv Akut Kardiol. 2014;13(2):63-66

A survey of patients treated for infective endocarditis at cardiac-surgery department

Petra Pešová, Radim Brát
Kardiochirurgické centrum, Fakultní nemocnice Ostrava

of University Hospital Ostrava in 1998–2012

Purpose: Infective endocarditis is a disease with a relatively low incidence and high mortality. In our study, we present the results of

a range of patients operated at cardiac-surgery department of the University Hospital Ostrava for acute infective endocarditis in 1998–2012.

Methods: This is a retrospective series of patients admitted to our department in the years 1998–2006 (group A) and in the years 2007–2012

(group B) with a diagnosis of acute infective endocarditis by DUKE criteria. We followed and compared in each file location of affected

valve, indication for surgery, causative microorganisms, presence of local complications and mortality and recurrence of the disease.

Results: In 1998–2006 there were in our center operated a total of 67 patients with the diagnosis, the most widespread cause for cardiosurgical

performance was congestive heart failure, predominant was left-sided endocarditis of native valves, etiologically dominated by

group of streptococci and Staphylococcus aureus, the overall mortality in this group of patients was 13.5 %, and recurrence was 6 %. In

2007–2012 71 patients were operated in our centre, the most widespread cause for cardiosurgical performance was uncontrolled infection,

etiologically dominated group of streptococci, the overall mortality in this group of patients was 7 %, and recurrence was 2,8 %.

Conclusions: Compared both group there is a shift in the number of locally complicated endocarditis, growing almost three times the

number of left-sided prosthetic endocarditis, twice the number of right-sided valvular endocarditis, there is a change in epidemiology and

a decrease in overall mortality and recurrence. Despite advances in diagnosis of disease, the number of blood-culture negative IE is increasing.

A limitation of our study is the relatively uneven group of patients and the absence of long-term monitoring of surviving patients.

Keywords: infective endocarditis, indication, surgery, mortality

Published: May 15, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pešová P, Brát R. A survey of patients treated for infective endocarditis at cardiac-surgery department. Interv Akut Kardiol. 2014;13(2):63-66.
Download citation

References

  1. Beneš J, Gregor P, Mokráček A. Infekční endokarditida. Doporučené postupy diagnostiky, léčby, dispenzarizace a profylaxe. Cor et vasa 2007; 6: 157-171.
  2. Habib G, Hoen B, Torno P, et al. Guidelines on the prevention, diagnosis and treatment of infective endocarditis (new version 2009), ESC guidelines, European Heart Journal 2009; 30: 2369-2413. Go to original source... Go to PubMed...
  3. Hoen B, Alla F, Selton-Suty C, et al. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 2002; 288: 75-81. Go to original source... Go to PubMed...
  4. Hogevik H, Olaison L, Andersson R, et al. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 1995; 74: 324-339. Go to original source... Go to PubMed...
  5. Berlin JA, Abrutyn E, Strom BL, et al. Incidence of infective endocarditis in the Delaware Valley, 1988-1990. Am J Cardiol 1995; 76: 933-936. Go to original source... Go to PubMed...
  6. Van der Meer JT, Thompson J, Valkenburg HA, et al. Epidemiology of bacterial endocarditis in The Netherlands. I. Patient characteristics. Arch Intern Med 1992; 152: 1863-1868. Go to original source...
  7. Castillo JC, Anguita MP, Ramirez A, et al. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study. Heart 2000; 83: 525-530. Go to original source... Go to PubMed...
  8. Wang A, Athan E, Pappas PA, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007; 297: 1354-1361. Go to original source... Go to PubMed...
  9. Aksoy O, Sexton DJ, Wang A, et al. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis 2007; 44: 364-372. Go to original source... Go to PubMed...
  10. Thuny F, Beurtheret S, Mancini J, et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J 2011; 32: 2027-2033. Go to original source... Go to PubMed...
  11. Malhorta A, Prendergast BD. Evaluating treatment options for patients with infective endocarditis: when is the right time for surgery? Future Cardiol. 2012; 8: 847-861. Go to original source... Go to PubMed...
  12. San Roman JA, Lopez J, Vilacosta I, et al. Prognostic stratification of patients with left-sided endocarditis determined at admission. Am J Med 2007; 120: 369 e1-e7. Go to original source... Go to PubMed...
  13. Chu VH, Cabell CH, Benjamin DK Jr, et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004; 109: 1745-1749. Go to original source... Go to PubMed...
  14. Hasbun R, Vikram HR, Barakat LA, et al. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003; 289: 1933-1940. Go to original source... Go to PubMed...
  15. Delahaye F, Alla F, Beguinot I, Bruneval P, et al. In-hospital mortality of infective endocarditis: prognostic factors and evolution over an 8-year period. Scand J Infect Dis 2007; 39: 849-857. Go to original source... Go to PubMed...
  16. Moreillon P, Que YA. Infective endocarditis. Lancet 2004; 363: 139-149. Go to original source... Go to PubMed...
  17. Baddour L, Wilson WR, Bayer AS, et al. Infective endokarditis: Diagnosis, Antimicrobial Therapy and Management of Complication. Circulation. 2005; 111: 3167-3184. Go to original source...
  18. Aksoy O, Meyer LT, Cabell CH, et al. Gender differences in infective endocarditis: pre and co-morbid condition lead to different management and outcomes in female patients. Scan J Infect Dis 2007; 39: 101-107. Go to original source... Go to PubMed...
  19. Kaiser SP, Melby SJ, Zierer A, et al. Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg 2007; 83: 30-35. Go to original source... Go to PubMed...
  20. David TE, Gavra G, Feindel CM, et al. Surgical treatment of active infective endocarditis: a continued challenge. J Thorac Cardiovasc Surg 2007; 133: 144-149. Go to original source... Go to PubMed...
  21. Heiro M, Helenius H, Hurme S, et al. Long-term outcome of infective endocarditis: a study on patients surviving over one year after the initial episode treated in a Finnish teaching hospital during 25 years. BMC Infect Dis 2008; 8: 49. Go to original source... Go to PubMed...
  22. Mansur AJ, Dal Bo CM, Fukushima JT, et al. Relapses, recurrences, valve replacements, and mortality during the long-termfollow-up after infective endocarditis. Am Heart J 2001; 141: 78-86. Go to original source... Go to PubMed...
  23. Renzulli A, Carozza A, Romano G, et al. Recurrent infective endocarditis: a multivariate analysis of 21 years of experience. Ann Thorac Surg 2001; 72: 39-43. Go to original source... Go to PubMed...
  24. Wilson W, Taubert KA, Gewitz M. Prevention of infective endocarditis. Guidelines from American heart association. Circulation 2007; 116: 1736-1754. Go to original source... Go to PubMed...
  25. Duval X, Alla F, Hoen B, et al. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic profylaxis. Clin.Infect Dis 2006; 45: 102-107. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.